Boston Scientific

Open: 55.41 Close: 55.95 Change: 0.54

Our AI found unexpected things about Boston Scientific.

The game is changing. There is a new strategy to evaluate Boston Scientific fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, BSX, stock, NYSE, Corp, company, …

Concept Map

Semantic Network

Stock Summary

Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat.

Today's Summary

Boston Scientific Corp. stock underperforms monday when compared to competitors despite daily gains - marketwatch. boston scientific corp. stock outperforms market - market watch. bostost scientific corp. stock outperforming market.

Today's News

Boston Scientific Corp. stock underperforms monday when compared to competitors despite daily gains - marketwatch. boston scientific corp. stock outperforms market - market watch. The company reported revenue of $3.5 billion and adjusted earnings of $0.50. Sustaining Project Manager, I Work mode:  Hybrid Onsite Location(s):  Maple Grove, MN, US, 55311 Additional Location(S):   N/A Diversity - Innovation - Caring - Global Collaboration - Winning Spirit - High Performance. Meet Three Boston Scientific Employees Committed to Protecting People From Stroke. The Peripheral Interventions team with Boston Scientific is looking for high energy, driven, and passionate people who are not just looking for a job but for a career. Boston Scientific: When a loved one has Parkinsons disease. HUBC HUB Announces Reverse Share Split. Boston Scientific (BSX) Announces Positive Impact of Treatment on Parkinsinsons Disease Patient. Boston Scientific has been making a number of investments not only in Ireland but also across the full breadth of its global operations. The company has either met or is on track to meet all its decarbonisation goals – The companys investment, development and adherence to the GEMS framework has been a key success. Boston Scientific (NYSE: BSX) is proud to be an equal opportunity and affirmative action employer. Boston Scientific maintains a prohibited substance free workplace. Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. The 52-week high for the BSX share is $55.38. The company operates in the medical devices sector. Boston Scientific Corp. generated net sales of $3.127 billion during the fourth quarter of 2021, growing 15.4 percent on a reported basis, 16.9 percent on an operational1 basis. This compares with 1% and -16% returns for the broader S&P500 index. Boston Scientific stock (NYSE: BSX) currently trades at $51 per share, roughly 30% above its level in March 2021. The public float for BSX is 1.46B, and at present, short sellers hold a 0.63% of that float. Find real-time BSX - Boston Scientific Corp stock quotes, company profile, news and forecasts from CNN Business. BSX stock is trading at 27x forward P/E based on our earnings forecast of $1.92 for 2023. Boston Scientific (BSX) has a current dividend yield of n/a this year. Abbott (NYSE: ABT) and Medtronic are the most likely potential buyers of ShockWave Medical. Boston Scientific Corp. (NYSE:BSX – Get Free Report) had its price objective upped by research analysts at Canaccord Genuity Group from $60.00 to $64.00 in a research report issued on Monday. Financially, BSX shows strong growth with net sales of a robust $3.52 billion, an 11.2%... Boston Scientific stock spiked 0.25% in intraday trading to $51.56 this Friday, 11/10/23, hitting a weekly high. Abbott (NYSE: ABT), Boston Scientific (NYSE) and Medtronic are the most likely potential buyers of ShockWave Medical. This role is deemed safety-sensitive and candidates will be subject to a drug test as a pre-employment requirement. Boston Scientific maintains a prohibited substance free workplace. Listen to the newest episode of our podcast with DeviceTalks. Paudie OConnor on managing supply chain volatility and sustainability. Pulse Biosciences is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. Boston Scientific has a beta of 0.78, indicating its stock price is 22%. Field Clinical Representative II for Spinal Cord Stimulator is New York City, NY. Work mode: Hybrid Preferred, Remote Considered Territory: United States Additional Location(s): N/A

Stock Profile

"Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts."

Keywords

Are looking for the most relevant information about Boston Scientific? Investor spend a lot of time searching for information to make investment decisions in Boston Scientific. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, BSX, stock, NYSE, Corp, company, and the most common words in the summary are: boston, scientific, job, bsx, stock, corporation, news, . One of the sentences in the summary was: boston scientific corp. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #boston #scientific #job #bsx #stock #corporation #news.